23andMe founder aims to restart auction with major corporate backing

23andMe founder aims to restart auction with major corporate backing#23andMe #founder #aims #restart #auction #major #corporate…

Regeneron's 23andMe Steal: Smart Genetics Play That Won't Cure Near-Term Growth Pains

Regeneron's 23andMe Steal: Smart Genetics Play That Won't Cure Near-Term Growth Pains #Regeneron039s #23andMe #Steal #Smart…

Pharma giant Regeneron to buy 23andMe and its customers’ data for $256M

Pharmaceutical maker Regeneron announced Monday it will buy genetic testing company 23andMe for $256 million following…

23andMe customers notified of bankruptcy and potential claims — deadline to file is July 14

23andMe, the genetic testing giant once valued in the billions, is now navigating Chapter 11 bankruptcy…

Congress has questions about 23andMe bankruptcy

3The leaders of the House Committee on Energy and Commerce said they are investigating how 23andMe’s…

23andMe files for bankruptcy: How to delete your data

DNA testing service 23andMe filed for bankruptcy protection on March 16, sparking concerns about what could…

23andMe faces an uncertain future — so does your genetic data 

DNA and genetic testing firm 23andMe is in turmoil following a 2023 data breach and its…

DNA testing company 23andMe files for bankruptcy protection, CEO resigns

Genetics testing company 23andMe has filed for Chapter 11 bankruptcy protection in the U.S. to initiate…

Controversial genetics testing startup Nucleus Genomics raises $14M Series A 

Last week, Founders Fund partner Delian Asparouhov realized he hadn’t checked on his genetics in a…

23andMe considers selling its telehealth unit Lemonaid By Investing.com

Investing.com — Genetic testing firm 23andMe is reportedly considering the sale of its telehealth division, Lemonaid…

These were the badly handled data breaches of 2024

For the past few years, TechCrunch has looked back at some of the worst, badly handled…